Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1)
- PMID: 19953642
- DOI: 10.1002/humu.21170
Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1)
Abstract
Phenocopies may confound the clinical diagnoses of hereditary disorders. We report phenocopies in Multiple Endocrine Neoplasia type 1 (MEN1), an autosomal dominant disorder, characterised by the combined occurrence of parathyroid, pituitary and pancreatic tumours. We studied 261 affected individuals from 74 families referred with a clinical diagnosis of MEN1 and sought inconsistencies between the mutational and clinical data. We identified four patients from unrelated families with phenocopies. Patients 1 and 2 from families with MEN1, developed prolactinomas as the sole endocrinopathy but they did not harbour the germline MEN1 mutation present in their affected relatives. Patient 3, had acromegaly and recurrent hypercalcaemia following parathyroidectomy, whilst patient 4 had parathyroid tumours and a microprolactinoma. Patients 3 and 4 and their relatives did not have MEN1 mutations, but instead had familial hypocalciuric hypercalcaemia (FHH) due to a calcium-sensing receptor mutation (p.Arg680Cys), and the hyperparathyroidism-jaw tumour (HPT-JT) syndrome due to a hyperparathyroidism type 2 deletional-frameshift mutation (c.1239delA), respectively. Phenocopies may mimic MEN1 either by occurrence of a single sporadic endocrine tumour in a patient with familial MEN1, or occurrence of two endocrine abnormalities associated with different aetiologies. Phenocopies arose in >5% of MEN1 families, and awareness of them is important in the clinical management of MEN1 and other hereditary disorders.
Similar articles
-
Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.Clin Endocrinol (Oxf). 2006 Feb;64(2):146-52. doi: 10.1111/j.1365-2265.2006.02438.x. Clin Endocrinol (Oxf). 2006. PMID: 16430712
-
Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.Clin Endocrinol (Oxf). 2006 Jul;65(1):9-16. doi: 10.1111/j.1365-2265.2006.02534.x. Clin Endocrinol (Oxf). 2006. PMID: 16817812
-
Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.Recent Prog Horm Res. 1999;54:397-438; discussion 438-9. Recent Prog Horm Res. 1999. PMID: 10548885 Review.
-
[Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].Dtsch Med Wochenschr. 2011 Sep;136(38):1889-94. doi: 10.1055/s-0031-1286358. Epub 2011 Sep 13. Dtsch Med Wochenschr. 2011. PMID: 21915802 German.
-
Molecular pathogenesis of primary hyperparathyroidism.J Endocrinol Invest. 2011 Jul;34(7 Suppl):35-9. J Endocrinol Invest. 2011. PMID: 21985978 Review.
Cited by
-
True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome.Endocrine. 2019 Aug;65(2):451-459. doi: 10.1007/s12020-019-01932-x. Epub 2019 May 1. Endocrine. 2019. PMID: 31044390 Free PMC article.
-
Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome.Front Endocrinol (Lausanne). 2023 Jul 7;14:1191040. doi: 10.3389/fendo.2023.1191040. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37484956 Free PMC article.
-
Long-term follow-up and novel splice donor mutation in MEN1 in a Chinese family.Oncotarget. 2017 Dec 7;9(2):1577-1586. doi: 10.18632/oncotarget.23100. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416715 Free PMC article.
-
A Pituitary Macroadenoma Cosecreting Prolactin and Growth Hormone in a Patient With Multiple Endocrine Neoplasia Type 4.JCEM Case Rep. 2025 May 29;3(7):luaf124. doi: 10.1210/jcemcr/luaf124. eCollection 2025 Jul. JCEM Case Rep. 2025. PMID: 40443455 Free PMC article.
-
Genotype-phenotype correlation in multiple endocrine neoplasia type 1.JCI Insight. 2025 Feb 13;10(6):e176993. doi: 10.1172/jci.insight.176993. JCI Insight. 2025. PMID: 39946193 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources